Overexpression of cyclin D1 in epithelial ovarian cancers

Gynecologic Oncology

Volumn 64, Issue 2, 1997, Pages 189-195

  Worsley, Sally D ^a   Ponder, Bruce A J ^a   Davies, Barry R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0031081264     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4569     Document Type: Article

References (38)

1. 1 cyclins. Curr Opin Cell Biol 6:8429-8460, 1994
2. 1. Genes Dev 7:812-821, 1993
3. 1 phase in rodent fibroblasts. Genes Dev 7:1559-1571, 1993
4. 4. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9:707-718, 1994
5. 5. Jiang W, Khan SM, Zhou P, Zhang YJ, Cacace AM, Infante AS: Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457, 1993
6. 6. Hartwell L: Defects in cell cycle checkpoints may be responsible for the genomic instability of cancer cells. Cell 71:543-546, 1992
7. 7. Almason A, Linke SP, Paulson TG, Wall GM: Genetic instability as a consequence of inappropriate entry into the cell cycle progression through S phase. Cancer Metast Rev 14:59-73, 1995
8. 8. Zhou P, Jiang W, Weghorst CM, Weinstein IB: Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56:36-39, 1996
9. 9. Sutherland RL, Hamilton JA, Sweeney KJE, Watts CKW, Musgrove EA: Expression and regulation of cyclin genes in breast cancer. Acta Oncol 34:651-656, 1995
10. 10. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukusima Y, Kronenberg HM: Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 83:2034-2040, 1989
11. 11. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A: Centrocytic lymphoma: A B-cell non-Hodgkin's lymphoma characterised by chromosome 11 bcl-1 and PRAD1 rearrangements. Curr Top Microbiol Immunol 182:325-329, 1992
12. 12. Brookes S, Lammie GA, Schuuring E, Dickson C, Peters G: Linkage map of a region of human chromosome band 11q13 amplified in breast and squamous cell tumors. Genes Chromosom Cancer 4:290-301, 1992
13. 13. Jiang W, Kahn SM, Tomita N, Zhang YJ, Lu SH, Weinstein IB: Amplification and expression of the human cyclin D1 gene in oesophageal cancer. Cancer Res 52:2980-2983, 1992
14. 14. Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-419, 1991
15. 15. Champeme MH, Bieche I, Lizard S, Liderau R: 11q13 amplification in local recurrence of human primary breast cancer. Genes Chromosom Cancer 12:128-133, 1995
16. 16. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFaxio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993
17. 17. Gillet C, Frantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunocytochemical staining. Cancer Res 54:1812-1817, 1994
18. 18. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361, 1994
19. 19. Worsley SD, Jennings BA, Khalil KH, Mole M, Girling AC: Cyclin D1 amplification and expression in human breast carcinoma: Correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol 49:M46-M50, 1996
20. 20. Michalides R, Hageman P, van Tinteren H, Houben L, Weintjens E, Klompmaker R, Pterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728-734, 1996
21. 21. Fantl V, Richards MA, Smith R: Gene amplification on chromosome band 11q13 and estrogen receptor status in breast cancer. Eur J Cancer 26:423-429, 1990
22. 22. Weinstat-Saslow D, Merlino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D mRNA distinguishes in situ and invasive breast carcinomas from non-malignant lesions. Nature Med 1:1256-1260, 1996
23. 23. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671, 1994
24. 24. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphoma genesis with the myc gene. EMBO J 13:2124-2130, 1994
25. 25. Campbell IG, Jones TA, Foulkes WD, Trowsdale J: Folate binding protein is a marker for ovarian cancer. Cancer Res 51:5329-5338, 1991
26. 26. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577, 1981
27. 27. Norton AJ, Jordan S, Yeomans P: Brief, high temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues. J Clin Pathol 173:371-379, 1994
28. 28. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper T, Dodge R, Clarke-Pearson P, McKenzie S, Yin S, Bast RC: Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 50:4087-4091, 1990
29. 29. Slamon DJ, Godolphin W, Jones LA, et al.: Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989
30. 30. Felip E, Del Campo JM, Rubio D, Vidal MT, Colomer R, Bermejo B: Overexpression of c-erb-B2 in epithelial ovarian cancer. Cancer 75:2147-2152, 1995
31. 31. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102:695-698, 1994
32. 32. Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102:695-698, 1994
33. 33. Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J: Cyclin D1 is dispensible for G1 control in retinoblastoma gene-deficient cells independent of cdk4 activity. Mol Cell Biol 15:2600-2611, 1995
34. 34. Rodabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS, Mok SC: Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors. Oncogene 11:1249-1254, 1995
35. 35. Campbell IG, Beynon G, Davis M, Englefield P: LOH and mutation analysis of CDKN2 in primary human ovarian cancers. Int J Cancer 63:222-225, 1995
36. 36. Dodson MK, Cliby WA, Xu HJ, DeLacey KA, Hu SX, Keeney GL, Li J, Podratz KC, Jenkins RB, Benedict WF: Evidence of functional Rb protein in epithelial ovarian carcinomas despite loss of heterozygosity at the Rb locus. Cancer Res 54:610-613, 1994
37. 37. Kim TM, Benedict WF, Xu HJ, Hu SX, Gosewehr J, Velicescu M, Yin E, Zheng J, D'Ablaing G, Dubeau L: Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression. Cancer Res 54:605-609, 1994
38. 38. Liu Y, Heyman M, Wang Y, Falkmer IJ, Hising C, Szekely L, Einhorn S: Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells. Int J Cancer 58:663-667, 1994